KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Efficacy and Safety of Bowel Cleansing with Mini S-Oral Sulfate Tablet versus the Conventional Oral Sulfate Tablet: A Prospective, Randomized, Investigator-Blinded, Multicenter, Noninferior, Phase 3 Trial.

Soo-Kyung Park, Seong Ran Jeon, Dong-Hoon Yang, Jaeyoung Chun, Jae Myung Cha

Gut Liver 20(2) 294-304

PMID41306094
PMCIDPMC12989664
DOI10.5009/gnl250291
发表日期2025-11-27
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:Fig. 1:图注未提示 KM 曲线;Fig. 2:图注未提示 KM 曲线;Fig. 3:非 KM 图。
摘要

摘要

BACKGROUND/AIMS: Conventional oral sulfate tablets (OSTs) and mini-OSTs have gained popularity for bowel preparation in South Korea. This study aimed to evaluate the efficacy, tolerability, and safety of mini S-OSTs, which have fewer tablets and include simethicone compared to the mini-OSTs. METHODS: This was a prospective, randomized, investigator-blinded, multicenter, and noninferior phase 3 trial conducted between August 2023 and January 2024. The efficacy, safety, and tolerability were compared among a mini S-OST split dose group, mini S-OST non-split dose group and conventional OST group. To evaluate the occurrence of gastric mucosal lesions, gastroscopy was also performed. RESULTS: High-quality preparation was achieved in the mini S-OST split dose group and conventional OST group according to both the full analysis set and per-protocol set analyses, without significant differences. Tolerability metrics were more favorable in the mini-OST group. The hematin content tended to decrease and the number of erosions was reduced in the mini S-OST split dose group compared with the conventional OST group according to the gastroscopy results. Adverse events were comparable between the conventional OST and mini S-OST split dose groups. The mini S-OST non-split dose group showed no difference in overall successful cleaning, but the proportion of high-quality cleaning in the ascending colon was lower than that in the mini S-OST split dose group and conventional OST group. CONCLUSIONS: Compared with conventional OST, the mini S-OST split dose showed excellent efficacy, comparable safety and tolerability, with less gastric injury (ClinicalTrial.gov identifier NCT06287606).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 1Flowchart of the study population. OST, oral sulfate tablet; FAS, full analysis set; PPS, per-protocol set.
非 KM Figure
Fig. 2Overall high-quality cleansing (A) and successful cleansing (B) in three groups: the mini S-OST split-dose group, mini S-OST non-split-dose group, and conventional OST group. Data are shown for both the FAS and PPS analyses. (A) Overall high-quality preparations were comparable between the mini S-OST and conventional OST groups in both the FAS (96.3% vs 98.2%, p=1.000) and the PPS analyses (96.3% vs 98.2%, p=1.000). (B) High rate of successful overall preparation (defined as an overall HCS grade of A or B) was observed in both the FAS (all 100% for three groups) and PPS analyses (all 100% for three groups). PPS, per-protocol set; FAS, full analysis set; OST, oral sulfate tablet; HCS, Harefield Cleansing Scale.
非 KM Figure
Fig. 3Kaplan-Meier analysis for the response time (median, minutes) from completion of preparation agents to first bowel movement in the three study groups: the mini S-OST split-dose group, mini S-OST non-split-dose group, and conventional OST group. Median response time was significantly faster in the mini S-OST group, regardless of the split or non-split regimen, than in the conventional OST group (62.5 minutes, 37.5 minutes vs 90.0 minutes, p=0.040, p<0.001, respectively). OST, oral sulfate tablet.
非 KM Figure